Jim Cramer Advises Holding Astera Labs Shares Amid Market Uncertainty Iran Strikes Test Market Optimism Despite NearDeal Signals Solmate Infrastructure CEO and Board Member Inject 114M in Shares Signaling Confidence in Solana Platform US Government Stake Bets IonQ Micron and Anduril Emerge as Top Candidates on Kalshi Disneys The Mandalorian and Grogu Opens to LowestEver Star Wars Box Office 82 Million Weekend CNBC Investing Club Portfolio Shows Divergent Returns Amid SixWeek Market Rally Immatics NV IMTX Q1 2026 Earnings EPS Misses Estimates as Clinical Progress Drives Share Gains Legato Merger Corp III LEGT Q1 2026 Earnings Positive EPS Reported Amid PreMerger Quiet Period 60 Degrees Pharmaceuticals Inc SXTP Q1 2026 Earnings EPS Misses Estimates No Revenue Yet TechPrecision Corporation TPCS Q1 2026 Earnings Narrowing Losses Amid Operational Adjustments RAPP Q1 2026 Earnings Narrower Loss Beats Street Estimates as PreRevenue Biotech Advances Pipeline AWK Q1 2026 Earnings EPS Misses Estimates as Shares Edge Higher Western Asset High Income Fund II HIX Edges Lower as Fixed Income Sentiment Remains Cautious FDBC Posts Modest Gain as Regional Bank Stock Nears Key Resistance News Corporation Shares Dip 141 as Stock Tests Key Support Levels NWSA LeMaitre Vascular Inc LMAT Holds Steady Near 98 as Traders Await Catalyst SELLAS Life Sciences Group SLS Gains Ground Biotech Stock Tests Key Resistance After 476 Rally AMT Q1 2026 Earnings Strong EPS Beat Driven by Solid Operational Performance EZRA Q1 2023 Earnings Massive EPS Beat Drives Stock Surge SES AI Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite WiderThanExpected Loss JNJ Q1 2026 Earnings EPS Slightly Beats Estimates No Revenue Data Disclosed Mount Logan Capital Inc Q1 2026 Earnings Net Loss Reported Amid Strategic Positioning Silicon Laboratories SLAB Q1 2026 Earnings BetterThanExpected Bottom Line Drives Slight Stock Uptick Hypothetical NASCAR Tragedy Sparks Debate on Indexed Universal Life Insurance Risks PERI Q1 2026 Earnings EPS Falls Short of Estimates Shares Decline Pacific Biosciences PACB Edges Higher But Key Resistance Remains a Hurdle